drugset / Trial / NCT02721563

A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC

NCT02721563 ↗

Phase 4 Completed 77 enrolled Shandong Cancer Hospital and Institute
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a perspective, multicenter,randomized controlled trial to evaluate the efficacy and safety of treatment with CMNa combined with concurrent chemoradiotherapy in patients with locally advanced squamous cell esophageal carcinoma . Analyses of primary objective (ORR) will be done as defined in the protocol.

Timeline

Start
2016-02-25
Primary completion
2018-06-10
Completion
2018-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sodium Glycididazole Small molecule 700 mg/m2 Intravenous

Indications